Clinical trials
Active, not recruiting Phase 1/2 Recurrence trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 5 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 29 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 3 |
| AbbVie | 2 |
| Amgen | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| St. Jude Children's Research Hospital | 2 |
| A2 Biotherapeutics Inc. | 1 |
| Allogene Therapeutics | 1 |
| ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 1 |
| Arsenal Biosciences, Inc. | 1 |
| Autolus Limited | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 29 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Leukemia | 4 |
| Lymphoma | 4 |
| Neoplasms | 4 |
| Leukemia, Myeloid, Acute | 3 |
| Neoplasm, Residual | 3 |
| Burkitt Lymphoma | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Central Nervous System Neoplasms | 2 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.